BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22451235)

  • 21. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
    Shaib WL; Jones JS; Goodman M; Sarmiento JM; Maithel SK; Cardona K; Kane S; Wu C; Alese OB; El-Rayes BF
    Oncologist; 2018 Jun; 23(6):704-711. PubMed ID: 29445028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare costs, treatment patterns, and resource utilization among pancreatic cancer patients in a managed care population.
    DaCosta Byfield S; Nash Smyth E; Mytelka D; Bowman L; Teitelbaum A
    J Med Econ; 2013 Dec; 16(12):1379-86. PubMed ID: 24074258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival analysis of veteran patients with pancreatic cancer.
    Kim D; Zhu H; Nassri A; Mokdad A; Kukreja S; Polanco P; Huerta S; Ramzan Z
    J Dig Dis; 2016 Jun; 17(6):399-407. PubMed ID: 27235863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
    [No Abstract]   [Full Text] [Related]  

  • 27. From street address to survival: Neighborhood socioeconomic status and pancreatic cancer outcomes.
    Eskander MF; Hamad A; Li Y; Fisher JL; Oppong B; Obeng-Gyasi S; Tsung A
    Surgery; 2022 Mar; 171(3):770-776. PubMed ID: 34876291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
    Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
    Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
    Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
    Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute pancreatitis as an early marker of pancreatic cancer and cancer stage, treatment, and prognosis.
    Kirkegård J; Gaber C; Lund JL; Hinton SP; Ladekarl M; Heide-Jørgensen U; Cronin-Fenton D; Mortensen FV
    Cancer Epidemiol; 2020 Feb; 64():101647. PubMed ID: 31811984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
    Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
    Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
    BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications.
    Zhu X; Chen D; Cao Y; Zhao X; Ju X; Shen Y; Cao F; Qing S; Fang F; Jia Z; Zhang H
    Cancer Biol Med; 2020 May; 17(2):492-500. PubMed ID: 32587784
    [No Abstract]   [Full Text] [Related]  

  • 35. Defining optimum treatment of patients with pancreatic adenocarcinoma using regret-based decision curve analysis.
    Hernandez JM; Tsalatsanis A; Humphries LA; Miladinovic B; Djulbegovic B; Velanovich V
    Ann Surg; 2014 Jun; 259(6):1208-14. PubMed ID: 24169177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of at least 1 mm as cut-off for resection margins for pancreatic adenocarcinoma of the body and tail.
    Hank T; Hinz U; Tarantino I; Kaiser J; Niesen W; Bergmann F; Hackert T; Büchler MW; Strobel O
    Br J Surg; 2018 Aug; 105(9):1171-1181. PubMed ID: 29738626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional targeting chemoimmunotherapy in patients undergoing pancreatic resection in an advanced stage of their disease: a prospective randomized study.
    Lygidakis NJ; Sgourakis G; Georgia D; Vlachos L; Raptis S
    Ann Surg; 2002 Dec; 236(6):806-13. PubMed ID: 12454519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival.
    Altman AM; Wirth K; Marmor S; Lou E; Chang K; Hui JYC; Tuttle TM; Jensen EH; Denbo JW
    Ann Surg Oncol; 2019 Nov; 26(12):4108-4116. PubMed ID: 31313044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic factors in ductal pancreatic cancer.
    Yeo CJ; Cameron JL
    Langenbecks Arch Surg; 1998 Apr; 383(2):129-33. PubMed ID: 9641885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.